Hypocalcaemia: EVENITY is contraindicated in patients with uncorrected hypocalcaemia [see Precautions, Adverse Reactions, and Use in Pregnancy & Lactation].
Hypersensitivity: EVENITY is contraindicated in patients with known clinically significant hypersensitivity to romosozumab or to any component of the product formulation [see Precautions and Description].